- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.02. | FDA relents and will review Moderna's flu shot | ||
| 18.02. | FDA changes course and agrees to review Moderna's flu shot | ||
| 18.02. | FDA starts review of BMS's 'celmod' for multiple myeloma | ||
| 18.02. | Number of UK biotech companies rising, says report | ||
| 18.02. | Novartis' oral BTK drug moves the needle in CINDU | ||
| 18.02. | NICE backs first disease-modifying drug for ARG1 deficiency | ||
| 17.02. | NHS study will pick apart mental illness with data science | ||
| 17.02. | Compass points to strong psilocybin data in depression | ||
| 17.02. | EU approval for new asthma drug Exdensur lifts GSK | ||
| 17.02. | Mark Dawson named head of Roche's pRED unit | ||
| 17.02. | Helus' psychedelic drug DMT 'could help treat depression' | ||
| 16.02. | UK seeks views on indefinite CE marks for medical devices | ||
| 16.02. | Roche trial offers hope to patients with rare kidney disease | ||
| 16.02. | AI in drug development news round-up | ||
| 16.02. | FDA turns down 'national priority' drug from Disc Medicine | ||
| 16.02. | Report says Jim O'Neill's time at HHS is nearing its end | ||
| 13.02. | Bankruptcy threat looms as Quince runs out of options | ||
| 13.02. | Lundbeck preps phase 3 for migraine prevention drug | ||
| 13.02. | PTC pulls file for Duchenne therapy on FDA feedback | ||
| 13.02. | ILiAD bags $115m for pertussis vaccine, and other financings | ||
| 12.02. | BridgeBio gains on phase 3 dwarfism data | ||
| 12.02. | Euro VCs team up to invigorate life sciences ecosystem | ||
| 12.02. | Zydus follows Lupin with Myrbetriq settlement deal | ||
| 12.02. | FDA says comparator dose scuppered Moderna's flu jab filing | ||
| 12.02. | Hudson out at Sanofi, as Belén Garijo named CEO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.